Tendee LogoChatBlog
Opportunità ta’ Tender Pubbliku

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS]

Ppubblikat f’ 23 ta’ Diċembru 2025

Tender Description

DURVALUMAB [50 MG/ ML 10 ML FRS]

Iftaħ Għarfien Sħiħ dwar it-Tender

Id-dettalji u l-analiżi AI kollha huma disponibbli fuq tend.ee. Oħloq kont bla ħlas.

Bla ħlas biex tibda. Ebda karta tal-kreditu meħtieġa.

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS] | Public Tender | tend.ee